Krystal Biotech (KRYS) P/E Ratio
P/E Ratio as of Jun 13, 2025: 33.01
Average31.57
Median31.61
Minimum29.71
Maximum33.79
33.01
Past Month+1.62 (5.16%)
The P/E ratio for Krystal Biotech (KRYS) is 33.01 as of Jun 13, 2025. This represents a decrease of -50.19% compared to its 12-month average P/E ratio of 66.27. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Krystal Biotech P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Krystal Biotech’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Krystal Biotech to industry peers.
Krystal Biotech P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Krystal Biotech’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Krystal Biotech to industry peers.
Krystal Biotech (KRYS) P/E Ratio Insights
See Krystal Biotech’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Krystal Biotech (KRYS)
Order type
Buy in
Order amount
Est. shares
0 shares
Krystal Biotech (KRYS) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $125.36 | 30.19 |
| May 1, 2025 | $165.69 | 55.45 |
| Apr 1, 2025 | $174.58 | 58.43 |
| Mar 3, 2025 | $171.83 | 57.51 |
| Feb 3, 2025 | $159.03 | 89.96 |
| Jan 2, 2025 | $156.50 | 88.53 |
Krystal Biotech (KRYS) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | 33.01 | -62.75% |
| 2024 | 88.62 | -204.36% |
| 2023 | -84.92 | +457.95% |
| 2022 | -15.22 | -31.84% |
| 2021 | -22.33 | -36.94% |
| 2020 | -35.41 | — |
FAQs About Krystal Biotech (KRYS) P/E ratio
The latest P/E ratio of Krystal Biotech (KRYS) is 33.01, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Krystal Biotech’s last 12-month average P/E ratio is 66.27, compared to its current P/E ratio of 33.01. This reflects a decrease of -50.19%.
Krystal Biotech’s current P/E ratio of 33.01 is lower than its last 12-month average P/E of 66.27. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Krystal Biotech’s average P/E ratio over the last 3 years is 142.35. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Krystal Biotech’s average P/E ratio over the last 5 years is 74.09. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.